Basic Information |
|
| Product Name： | GOSERELIN ACETATE |
| CAS： | 145781-92-6 ;65807-02-5 |
| English Synonyms： | GLP-HIS-TRP-SER-TYR-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ACETATE ; GOSERELIN ACETATE SALT ; PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH(2) ; GOSERELINA ACETATE ; (D-SER(TBU)6,AZAGLY10)-LHRH ACETATE ; DECAPEPTIDE I ACETATE ; GOSERELIN ; ICI 118630 ACETATE ; GOSERELIN ACETATE ; PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ACETATE SALT ; GLP-HIS-TRP-SER-TYR-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ; ZOLADEX ACETATE ; (D-SER(TBU)6,AZAGLY10)-LHRH ACETATE SALT ; GOSERELINUM ACETATE ; GOSERELINE ACETATE |
| MDL Number.： | MFCD01747329 |
| H bond acceptor： | 32 |
| H bond donor： | 18 |
| Smile： | CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O |
| InChi： | InChI=1S/C59H84N18O14.C2H4O2/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38;1-2(3)4/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90);1H3,(H,3,4)/t38-,39-,40-,41-,42-,43-,44-,45+,46-;/m0./s1 |
| InChiKey： | InChIKey=IKDXDQDKCZPQSZ-JHYYTBFNSA-N |
Property |
|
| Comments： | BIOCHEM/PHYSIOL ACTIONS: GOSERELIN IS A SYNTHETIC ANALOG OF LHRH (LEUTINIZING HORMONE RELEASING HORMONE). GOSERELIN IS A LHRH AGONIST IT IS USED IN PROSTATE CANCER AND BREAST CANCER THERAPIES AND ALSO IN THE TREATMENT OF ENDOMETRIOSIS GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA OTHER NOTES: SALES RESTRICTIONS MAY APPLY |
Safety information |
|
| WGK Germany： | 3 |
* If the product has intellectual property rights, a license granted is must or contact us.
2010-2021 © Chemical Cloud Database. ALL Rights Reserved.浙ICP备11020424号-1
浙公网安备 33010802004002号
中文版